Takeda pharmaceutical co ltd articles
-
E Fund Management Co. Ltd. Sells 6,346 Shares of Tesla, Inc. (NASDAQ:TSLA)
E Fund Management Co. Ltd. reduced its holdings in Tesla, Inc. (NASDAQ:TSLA – Free Report) by 18.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 28,500 shares of the electric vehicle producer’s stock after selling 6,346 shares during the quarter. Tesla […]
-
E Fund Management Co. Ltd. Lowers Stock Position in Keysight Technologies, Inc. (NYSE:KEYS)
E Fund Management Co. Ltd. decreased its position in Keysight Technologies, Inc. (NYSE:KEYS – Free Report) by 9.2% in the fourth quarter, Holdings Channel reports. The institutional investor owned 1,471 shares of the scientific and technical instruments company’s stock after selling 149 shares during the period. E Fund Management Co. Ltd.’s holdings in Keysight Technologies […]
-
E Fund Management Co. Ltd. Invests $314,000 in Morphic Holding, Inc. (NASDAQ:MORF)
E Fund Management Co. Ltd. purchased a new position in shares of Morphic Holding, Inc. (NASDAQ:MORF – Free Report) during the 4th quarter, HoldingsChannel.com reports. The firm purchased 10,888 shares of the company’s stock, valued at approximately $314,000. Several other hedge funds and other institutional investors also recently made changes to their positions in the […]